// App-Quantinova.ai

1343 : P32-targeting TT1 peptide delivers nanoparticles to intracranial glioblastomas

Researchers

Presenter

  • Pille Saalik

Principal Investigators

  • Hedi Hunt

  • Allan Tobi

  • Anne-Mari Anton Willmore

  • Kadri Toome

  • Shweta Sharma

  • Ramana Kotamraju

  • Gabriele Bergers

  • Rolf Bjerkvig

  • Erkki Ruoslahti

  • Tambet Teesalu

Medical Centers

  • Institute of Biomedicine and Translational Medicine, Tartu, Estonia

  • Sanford Burnham Prebys Medical Discovery Institute, Heidelberg, CA

  • UCSF Comprehensive Cancer Center, University of California, San Francisco, CA

  • Department of Clinical Medicine, University of Bergen, Bergen, Norway

Locations

  • Estonia

  • United States

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-Grade Gliomas

  • Glioblastoma

  • Solid malignancies

  • Gliomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved